The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG survey
Enrica Seravalli1, Petra S. Kroon1, John M. Buatti2, Matthew D. Hall3, Henry C. Mandeville4, Karen J. Marcus5, Cem Onal6, Enis Ozyar7, Arnold C. Paulino8, Frank Paulsen9, Daniel Saunders10, Derek S. Tsang11, Suzanne L. Wolden12, Geert O. Janssens1,13
1Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
2Departments of Radiation Oncology, University of Iowa, Iowa City, USA
3Department of Radiation Oncology, Miami Cancer Institute, Miami, FL, USA
4Department of Radiotherapy, The Royal Marsden Hospital and Institute of Cancer Research, Sutton, United Kingdom
5Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA
6Department of Radiation Oncology, Baskent University, Ankara, Turkey
7Department of Radiation Oncology, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey
8Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, USA
9Department of Radiation Oncology, University Hospital Tuebingen, Tuebingen, Germany
10The Christie NHS Foundation Trust, Manchester, UK
11Radiation Medicine Program, University Health Network – Princess Margaret Cancer Centre, Toronto, Canada
12Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, NY USA
13Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Clinical and Translational Radiation Oncology
Tập 29
71-78
Thông tin tác giả